Lv3
370 积分 2021-09-13 加入
A randomized, phase 3 study of datopotamab deruxtecan (Dato-DXd; DS-1062) versus docetaxel in previously treated advanced or metastatic non-small cell lung cancer (NSCLC) without actionable genomic alterations (TROPION-Lung01)
3个月前
已关闭
TROP-2–directed antibody–drug conjugates in advanced NSCLC: A systematic review and meta-analysis of efficacy, safety, and reconstructed survival outcomes
5个月前
已完结
TROP-2–directed antibody–drug conjugates in advanced NSCLC: A systematic review and meta-analysis of efficacy, safety, and reconstructed survival outcomes
5个月前
已完结
1292P Two single-arm, multicenter phase-II trials of PD-1 inhibitors in patients with pulmonary sarcomatoid carcinoma (NCCH1603/NCCH1703)
10个月前
已完结
Efficacy of First-Line Chemotherapy in Patients with Advanced Lung Sarcomatoid Carcinoma
10个月前
已完结
Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma
10个月前
已完结
1292P Two single-arm, multicenter phase-II trials of PD-1 inhibitors in patients with pulmonary sarcomatoid carcinoma (NCCH1603/NCCH1703)
10个月前
已关闭
The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma
10个月前
已完结
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
11个月前
已完结
皖公网安备34019202002308
